How alcohol affects the connection between the liver and brain in Alzheimer's disease.
Official title: Modulation of the liver-brain axis by alcohol and its impact on Alzheimers disease pathology
Funded at Keck Graduate Inst of Applied Life Scis · NIH-11131397 · Data updated 2026-11-12
This study is looking at how drinking too much alcohol might affect both the liver and the brain, especially in relation to Alzheimer's disease, to see if liver problems can lead to more amyloid-beta buildup in the brain and worsen the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keck Graduate Inst of Applied Life Scis NIH-funded |
| Lab location | 1 site (Claremont, United States) |
| Project start | September 30, 2020 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $83,347 |
| NIH project number | 3R01AG072896-05S1 |
| Project ID | NIH-11131397 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with a history of chronic alcohol use who are at risk for developing Alzheimer's disease.
✕Less likely to help
Patients who do not consume alcohol and have no risk factors for Alzheimer's disease may not benefit from this research.
What this research studies
This research investigates the effects of chronic alcohol consumption on the liver-brain axis and its potential role in promoting Alzheimer's disease pathology. The study aims to understand how changes in liver function, particularly the reduction of a receptor that helps clear amyloid-beta from the body, can influence the accumulation of this protein in the brain. Additionally, it examines how inflammatory signals from the liver may affect the blood-brain barrier and contribute to Alzheimer's disease progression. By using transgenic mouse models, the research seeks to uncover new mechanisms linking alcohol intake to Alzheimer's pathology.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease in individuals with a history of alcohol consumption.
How similar studies have gone: While the direct connection between alcohol, liver function, and Alzheimer's disease is still being explored, preliminary findings suggest that similar approaches have shown promise in understanding the disease's pathology.
Where this research is happening
-
Keck Graduate Inst of Applied Life Scis
Claremont, United States Active
Researchers
- Principal investigator: Han, Derick S — Keck Graduate Inst of Applied Life Scis
- Study coordinator: Han, Derick S
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
CLU's role in Alzheimer's disease pathogenesis
Researchers are studying how the CLU gene may drive brain changes in Alzheimer's disease and how targeting CLU could lead to safer treatments.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.